Brief: Index Pharmaceuticals Q2 Operating Loss At SEK 21.7 Mln

Flerie AB

26/08/2022 07:20

Aug 26 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS HOLDING AB (PUBL) INTERIM REPORT
JANUARY -
JUNE 2022
    * Q2 NET SALES AMOUNTED TO SEK 0.0 (0.0) MILLION
    * Q2 OPERATING LOSS AMOUNTED TO SEK -21.7 (-42.6) MILLION
    * Q2 RESULT AFTER TAX AMOUNTED TO SEK -21.7 (-42.6) MILLION

Source text for Eikon:  ID:nWkr7B7sHw 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))